Takhzyro Approved for Pediatric Hereditary Angioedema
The approval was supported extrapolation of efficacy data from the phase 3 HELP study, along with safety and pharmacodynamic data from the phase 3 SPRING study.
The approval was supported extrapolation of efficacy data from the phase 3 HELP study, along with safety and pharmacodynamic data from the phase 3 SPRING study.
Odactra is an allergen extract indicated as immunotherapy for the treatment of HDM-induced allergic rhinitis.
Researchers evaluated whether there is an association between rotavirus infection and extraintestinal complications in pediatric patients.
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
A survey developed by pediatricians and allergists identified current practices regarding the introduction of food allergens to children aged 7 months to 3.5 years.
Researchers assessed protection against COVID-19 Delta and Omicron infection among adolescents who were either vaccinated, previously infected, or had hybrid immunity.
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Researchers sought to analyze COVID-19 vaccination status among parents of hospitalized children younger than age 5 years with COVID-19 infection during the Delta and Omicron waves.
The INTEGUMENT-2 trial included patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.